Episode 2 of 3
Update on MPN Clinical Trials and new drugs in development for 2021 and beyond. The PDUFA date is the end of the review period, where the FDA has to make a decision or respond to a New Drug Application (NDA) or a Biologics License Application (BLA). Ropeginterferon and Pacritinib both have PDUFA dates in November 2021.
How do you evaluate a patient’s disease? How and when do you approach the clinical trial topic with patients? If I participate in a clinical trial will a bone marrow biopsy be required? Are clinical trials a last resort? Are MPNs a cancer / leukemia?
Dr. Andrew Kuykendall, Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center is our MPN specialist answering these questions and more. Ruth Fein is our host and patient advocate.
Try our new Clinical Trial Finder to search for new treatments and medical approaches for your myelofibrosis (MF), polycythemia vera (PV) or essential thrombocythemia (ET). It’s free and no personal information is required.